UC WAR. CALL 12/25 FRE/ DE000HD1ER81 /
2024-06-05 9:41:35 PM | Chg.+0.0600 | Bid9:59:39 PM | Ask9:59:39 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.7400EUR | +8.82% | 0.5600 Bid Size: 6,000 |
0.9200 Ask Size: 6,000 |
FRESENIUS SE+CO.KGAA... | 45.00 - | 2025-12-17 | Call |
GlobeNewswire
04-23
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2023-09-04
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
2023-08-31
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
2022-02-25
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire
2022-01-05
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire
2021-12-31
CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire
2021-12-09
Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire
2021-11-22
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
2021-11-22
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
2021-11-12
Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire
2021-10-27
CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire
2021-10-26
Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...